Medicalgorithmics enters supply agreement with CardioScan, a global leader in cardiac diagnostics – 800,000 tests annually in 11 countries
The Warsaw Stock Exchange-listed Polish medtech company has signed an agreement with global cardiac diagnostics leader, Australian-based CardioScan, which operates across North America, Asia, Oceania, and Europe. Under the agreement, Medicalgorithmics’ innovative software – the DeepRhythm Platform (DRP) and DeepRhythmAI (DRAI) artificial intelligence algorithms – will be available to CardioScan’s clients after integration and regulatory approval. This is the second partnership in Australia and the twelfth agreement signed by the Polish medtech firm this year.